+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Omega-3 fatty acids and cardiovascular disease: a case for omega-3 index as a new risk factor

Omega-3 fatty acids and cardiovascular disease: a case for omega-3 index as a new risk factor

Pharmacological Research 55(3): 217-223

The omega-3 fatty acids (FAs) found in fish and fish oils (eicosapentaenoic and docosahexaenoic acids, EPA and DHA) have been reported to have a variety of beneficial effects in cardiovascular diseases. Ecological and prospective cohort studies as well as randomized, controlled trials have supported the view that the effects of these FAs are clinically relevant. They operate via several mechanisms, all beginning with the incorporation of EPA and DHA into cell membranes. From here, these omega-3 FA alter membrane physical characteristics and the activity of membrane-bound proteins, and once released by intracellular phospholipases, can interact with ion channels, be converted into a wide variety of bioactive eicosanoids, and serve as ligands for several nuclear transcription factors thereby altering gene expression. In as much as blood levels are a strong reflection of dietary intake, it is proposed that an omega-3 FA biomarker, the omega-3 index (erythrocyte EPA+DHA) be considered at least a marker, if not a risk factor, for coronary heart disease, especially sudden cardiac death. The omega-3 index fulfils many of the requirements for a risk factor including consistent epidemiological evidence, a plausible mechanism of action, a reproducible assay, independence from classical risk factors, modifiability, and most importantly, the demonstration that raising tissue levels will reduce risk for cardiac events. For these and a number of other reasons, the omega-3 index compares very favourably with other risk factors for sudden cardiac death.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 016541482

Download citation: RISBibTeXText

PMID: 17324586

DOI: 10.1016/j.phrs.2007.01.013

Related references

Cardiovascular effects of omega 3 fatty acids. Atherosclerosis risk factor modification by omega 3 fatty acids. World Review of Nutrition and Dietetics 66: 218-232, 1991

Cardiovascular effects of omega 3 fatty acids atherosclerosis factor modifications by omega 3 fatty acids. Simopoulos, A P , Et Al (Ed ) World Review Of Nutrition And Dietetics, Vol 66 Health Effects Of Omega-3 Polyunsaturated Fatty Acids in Seafoods; Meeting, Washington, D C , Usa, March 20-23, 1990 Xxiv+592p S Karger Ag: Basel, Switzerland; New York, New York, Usa Illus 218-232, 1991

Omega-3 supplements and cardiovascular disease. Re: Sperling LS, Nelson JR. History and future of omega-3 fatty acids in cardiovascular disease. Curr Med Res Opin 2015: 32(2);301-311. Current Medical Research and Opinion 32(3): 583-584, 2016

Omega-3 fatty acids vs. cardiac disease--the contribution of the omega-3 index. Cellular and Molecular Biology 56(1): 93, 2010

Anti-inflammatory effects of omega 3 and omega 6 polyunsaturated fatty acids in cardiovascular disease and metabolic syndrome. Critical Reviews in Food Science and Nutrition 57(16): 3421-3429, 2017

Omega-3 polyunsaturated fatty acids and cardiovascular disease: an emphasis on omega-3-acid ethyl esters 90 for the treatment of hypertriglyceridemia. Expert Review of Cardiovascular Therapy 12(11): 1261-1268, 2014

The balance between omega-6 and omega-3 fatty acids and the risk of coronary heart disease. Nutrition 17(9): 741-742, 2001

Dietary omega-3, omega-6, and omega-9 unsaturated fatty acids and growth factor and cytokine gene expression in unstimulated and stimulated monocytes. A randomized volunteer study. Arteriosclerosis Thrombosis and Vascular Biology 19(1): 59-66, 1999

Achieving balance in the omega-6/omega-3 ratio through nutrigenomics: fat-1 transgenic mice convert omega-6 to omega-3 fatty acids. Nutrigenetics and nutrigenomics: 92-98, 2004

Genetic variants in the metabolism of omega-6 and omega-3 fatty acids: their role in the determination of nutritional requirements and chronic disease risk. Experimental Biology and Medicine 235(7): 785-795, 2010

Studies on the substrate specificity of soybean lipoxygenase 1 using an entire series of omega 3z omega 6z omega 9z c 12 c 22 trienoic acids and omega 3z omega 6z omega 9z c 12 c 22 trienols. Zeitschrift fuer Naturforschung Section C Journal of Biosciences 45(11-12): 1161-1164, 1990

Changes in plasma and erythrocyte omega-6 and omega-3 fatty acids in response to intravenous supply of omega-3 fatty acids in patients with hepatic colorectal metastases. Lipids in Health and Disease 12: 64, 2013

Treatment with omega-3 polyunsaturated fatty acids does not improve endothelial function in patients with type 2 diabetes and very high cardiovascular risk: A randomized, double-blind, placebo-controlled study (Omega-FMD). Atherosclerosis 271: 148-155, 2018

The essential fatty acids omega 3 and omega 6 fatty acids their significance for the prevention and rehabilitation of cardiovascular diseases. Deutsche Zeitschrift fuer Sportmedizin 38(12): 488-490, 492, 494, 496, 1987

Effects of omega-3 fatty acids on cardiovascular risk factors and intermediate markers of cardiovascular disease. Evidence Report/Technology Assessment 2004(93): 1-6, 2004